Gabriel Capella Selected Research

Gabriel Capella Research Topics

Disease

27	Neoplasms (Cancer) 02/2022 - 08/2002
13	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2003
4	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 03/2013
3	Carcinoma (Carcinomatosis) 01/2010 - 03/2007
3	Colonic Neoplasms (Colon Cancer) 01/2008 - 03/2007
2	Adenocarcinoma 01/2022 - 11/2021
2	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 07/2009
2	Microsatellite Instability 02/2014 - 03/2009
2	Carcinogenesis 12/2013 - 04/2009
2	Inflammation (Inflammations) 03/2007 - 07/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022
1	Febrile Neutropenia 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Enterocolitis 01/2022
1	Neurofibrosarcoma (MPNST) 01/2020
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2016
1	Ovarian Epithelial Carcinoma 10/2012
1	Neoplasm Metastasis (Metastasis) 07/2009
1	Polyps 04/2009
1	Stomach Neoplasms (Stomach Cancer) 11/2007
1	Atrophic Gastritis 11/2007
1	Adenoma (Adenomas) 03/2007

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 09/2016 - 09/2006
3	Biological ProductsIBA 01/2022 - 07/2003
3	Pharmaceutical PreparationsIBA 11/2021 - 10/2012
3	Messenger RNA (mRNA)IBA 01/2010 - 03/2004
2	130-nm albumin-bound paclitaxelIBA 01/2022 - 01/2020
2	Gemcitabine FDA Link 01/2022 - 01/2020
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2022 - 11/2021
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2017
2	Transforming Growth Factor-beta Type I ReceptorIBA 01/2019 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 10/2012
2	Cetuximab (Erbitux)FDA Link 04/2013 - 01/2010
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 11/2007 - 08/2002
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	AntibodiesIBA 11/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	trametinibIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Everolimus FDA Link 01/2020
1	palbociclibIBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	ChemokinesIBA 01/2019
1	CytokinesIBA 01/2019
1	Calcibiotic Root Canal SealerIBA 01/2019
1	RV 538 (PDMP)IBA 01/2018
1	H-cadherin (T-cadherin)IBA 09/2016
1	Cysteine (L-Cysteine)FDA Link 09/2016
1	Histamine Receptors (Histamine Receptor)IBA 09/2016
1	ProstaglandinsIBA 12/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2013
1	Epithelial Cell Adhesion MoleculeIBA 03/2013
1	PM 01183IBA 10/2012
1	Sepharose (Agarose)IBA 01/2011
1	OligonucleotidesIBA 01/2011
1	N 30IBA 05/2010
1	ParaffinIBA 05/2010
1	A-factor (Streptomyces)IBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Transcription Factors (Transcription Factor)IBA 07/2009
1	beta CateninIBA 04/2009
1	LigandsIBA 04/2009
1	trans-activation responsive RNA-binding proteinIBA 03/2009
1	MicroRNAs (MicroRNA)IBA 03/2009
1	Caspase 3 (Caspase-3)IBA 01/2008
1	Carcinoembryonic AntigenIBA 01/2008
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2007
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2007
1	HomocysteineIBA 11/2007
1	Pepsinogen A (Pepsinogen)IBA 11/2007
1	ChromatinIBA 07/2007
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2007
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	adenovirus associated RNA (VA RNA)IBA 09/2006
1	arginylprolineIBA 03/2004
1	Codon (Codons)IBA 03/2004
1	Interleukin-6 (Interleukin 6)IBA 07/2003
1	Interleukin-8 (Interleukin 8)IBA 07/2003
1	InterleukinsIBA 07/2003
1	PPAR gammaIBA 07/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003
1	Cellular Retinol-Binding ProteinsIBA 10/2002
1	RetinoidsIBA 10/2002

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
4	Therapeutics 01/2020 - 01/2010
3	Salpingo-oophorectomy 01/2021 - 07/2020
3	Hysterectomy 01/2021 - 07/2020
2	Adjuvant Chemotherapy 02/2014 - 01/2008
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2020
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 07/2020
1	Radiotherapy 01/2010
1	Transplantation 07/2009